White label ELPA - ClinicalTrials.eu

Study on the Effect of Chemotherapy with Ifosfamide, Dacarbazine, and Epirubicin Hydrochloride Before Surgery for Patients with High-Risk Retroperitoneal Sarcoma

Recruiting

3 1 1 1
Investigated Drugs:
+4
Study on Infection Prevention in Joint Replacement Surgery Using Povidone, Chlorhexidine, and Vancomycin for Adult Patients

Recruiting

3 1 1 1
Investigated Drugs:
Study on Tocilizumab for Treating Acute Chest Syndrome in Children and Adults with Sickle Cell Disease

Recruiting

3 1 1
Investigated Diseases:
- Sickle cell disease
Investigated Drugs:
- Sodium Chloride
- Tocilizumab
Study on Early Detection and Treatment of ER Positive HER2 Negative Breast Cancer Using Palbociclib, Fulvestrant, and Drug Combination for Patients with Molecular Relapse

Recruiting

2 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
Study on Sirolimus and Mycophenolate Mofetil for Reducing Hernia Risk in Type 1 Diabetes Patients with End-Stage Kidney Disease Undergoing Pancreas and Kidney Transplantation

Recruiting

3 1 1 1
Investigated Drugs:
- Sirolimus
- Mycophenolate Mofetil
Study on Imatinib for Patients with Triple Negative Breast Cancer to Convert it to ER-Positive Breast Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
- Imatinib
Safe Discontinuation of Antidepressants in Patients with Remitted Depression: Amitriptyline, Fluoxetine, Paroxetine, and Drug Combination Study

Recruiting

3 1 1 1
Investigated Diseases:
- Depression
Investigated Drugs:
Study on the Effectiveness and Safety of Ademetionine with Antidepressants for Patients with Major Depressive Disorder

Recruiting

3 1 1
Investigated Drugs:
- Ademetionine
Comparison of dapagliflozin and oral semaglutide effectiveness in type 2 diabetes patients based on insulin resistance or secretion deficit

Recruiting

3 1 1 1
Investigated Diseases:
- Type 2 diabetes mellitus
Investigated Drugs:
Study on Post-Neoadjuvant Therapy for Early Breast Cancer Using Ipatasertib, Inavolisib, and Atezolizumab for Patients with High-Risk Early Breast Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies